Remedium Lifecare
Remedium Lifecare
Commercial ServicesKey Fundamentals
MicrocapTrading & DistributorsCommercial ServicesTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Stock is trading at 0.22 times its book value
Weaknesses
4- Company has low interest coverage ratio.
- Promoter holding is low: 1.13%
- Earnings include an other income of Rs.10.8 Cr.
- Company has high debtors of 695 days.
Growth Rate
Quarterly Results
| Particulars | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|
| Sales | 264 | 113 | 111 |
| Expenses | 265 | 112 | 104 |
| Operating Profit | -0.46 | 1.87 | 7.38 |
| OPM % | -0.17% | 1.65% | 6.65% |
| Other Income | 0.66 | 3.48 | 3.25 |
| Interest | 1.59 | -0.36 | 0.19 |
| Depreciation | 0.01 | 0 | 0 |
| PBT | -1.4 | 5.71 | 10.44 |
| Tax % | 45.71% | 18.56% | 17.34% |
| Net Profit | -2.05 | 4.65 | 8.62 |
| EPS in Rs | -0.02 | 0.05 | 0.1 |
Profit & Loss
| Particulars | Mar 2025 |
|---|---|
| Sales | 405 |
| Expenses | 404 |
| Operating Profit | 1 |
| OPM % | 0.3% |
| Other Income | 11 |
| Interest | 8 |
| Depreciation | 0 |
| PBT | 4 |
| Tax % | 51% |
| Net Profit | 2 |
| EPS in Rs | 0.02 |
| Div. Payout % | 0% |
Balance Sheet
| Particulars | Mar 2025 | Sep 2025 |
|---|---|---|
| Equity Capital | 40 | 88 |
| Reserves | 4 | 17 |
| Borrowings | 1,141 | 1,088 |
| Other Liabilities | 535 | 430 |
| Total Liabilities | 1,720 | 1,623 |
| Fixed Assets | 0 | 6 |
| CWIP | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 1,720 | 1,617 |
| Total Assets | 1,720 | 1,623 |
Cash Flow
| Particulars | Mar 2025 |
|---|---|
| Operating | -1,135 |
| Investing | 0 |
| Financing | 1,136 |
| Net Cash Flow | 1 |
| Free Cash Flow | -1,135 |
| CFO/OP | -90,064 |
Ratios
| Particulars | Mar 2025 |
|---|---|
| Debtor Days | 695 |
| Inventory Days | 247 |
| Days Payable | 459 |
| Cash Conversion Cycle | 483 |
| Working Capital Days | 38 |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Remedium Lifecare insights
58 extracted metrics + investor summaries across FY11–FY25.
Documents
Frequently Asked Questions about Remedium Lifecare
What does Remedium Lifecare Ltd do?
Where is Remedium Lifecare Ltd (539561) listed?
Which sector does Remedium Lifecare Ltd belong to?
What is the market capitalisation of Remedium Lifecare Ltd?
What is the PE ratio of Remedium Lifecare Ltd?
What is the 52-week high and low of Remedium Lifecare Ltd?
What is the Return on Equity (ROE) of Remedium Lifecare Ltd?
Company Information
Supha Pharmachem Ltd, formerly Remedium Lifecare, is a pharmaceutical supply-chain trader of APIs, advanced intermediates, KSMs/CRMs and other pharma chemicals for domestic and export markets. It operates through the Indian parent and Singapore subsidiary Remlife Global Pte Ltd and entered CIRP on March 17, 2026. [1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539561.md for Remedium Lifecare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.